Cargando…

c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo

Altered synaptic function is considered one of the first features of Alzheimer disease (AD). Currently, no treatment is available to prevent the dysfunction of excitatory synapses in AD. Identification of the key modulators of synaptopathy is of particular significance in the treatment of AD. We her...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sclip, A, Tozzi, A, Abaza, A, Cardinetti, D, Colombo, I, Calabresi, P, Salmona, M, Welker, E, Borsello, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040696/ https://www.ncbi.nlm.nih.gov/pubmed/24457963 http://dx.doi.org/10.1038/cddis.2013.559

Ejemplares similares

c-Jun N-terminal kinase pathway activation in human and experimental traumatic brain injury: neuroprotective effects of its inhibition
por: Ortolano, F, et al.
Publicado: (2008)

Evidence of Presynaptic Localization and Function of the c-Jun N-Terminal Kinase
por: Biggi, Silvia, et al.
Publicado: (2017)

The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies
por: Buccarello, Lucia, et al.
Publicado: (2017)

Pharmacological c-Jun NH(2)-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice
por: Schellino, Roberta, et al.
Publicado: (2018)

c-Jun N-terminal kinase 1 (JNK1) modulates oligodendrocyte progenitor cell architecture, proliferation and myelination
por: Lorenzati, Martina, et al.
Publicado: (2021)

Jun N-terminal kinase signaling makes a face
por: Hursh, Deborah A., et al.
Publicado: (2016)

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
por: Yarza, Ramon, et al.
Publicado: (2016)

c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s Diseases
por: Hepp Rehfeldt, Stephanie Cristine, et al.
Publicado: (2020)

c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteins
por: Schmit, Travis L, et al.
Publicado: (2013)

Synaptic alterations as a common phase in neurological and neurodevelopmental diseases: JNK is a key mediator in synaptic changes
por: Musi, Clara Alice, et al.
Publicado: (2022)

c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1
por: Tian, Xiaodong, et al.
Publicado: (2021)

Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons
por: Ploia, Cristina, et al.
Publicado: (2010)

Involvement of homodomain interacting protein kinase 2‐c‐Jun N‐terminal kinase/c‐Jun cascade in the long‐term synaptic toxicity and cognition impairment induced by neonatal Sevoflurane exposure
por: Liang, Lirong, et al.
Publicado: (2020)

Inhibitors of c-Jun N-terminal kinases—JuNK no more?
por: Bogoyevitch, Marie A., et al.
Publicado: (2008)

Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation
por: Anfinogenova, Nina D., et al.
Publicado: (2020)

JNK Contributes to Hif-1α Regulation in Hypoxic Neurons
por: Antoniou, Xanthi, et al.
Publicado: (2009)

c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases
por: Guma, Monica, et al.
Publicado: (2012)

c-Jun N-terminal kinase activation has a prognostic implication and is negatively associated with FOXO1 activation in gastric cancer
por: Choi, Youngsun, et al.
Publicado: (2016)

Evolutionary Conserved Role of c-Jun-N-Terminal Kinase in CO(2)-Induced Epithelial Dysfunction
por: Vadász, István, et al.
Publicado: (2012)

An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicity in Vivo
por: Fluharty, Brian R., et al.
Publicado: (2013)

C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes
por: Duong, Men Thi Hoai, et al.
Publicado: (2020)

C‐Jun N‐terminal kinase signalling pathway in response to cisplatin
por: Yan, Dong, et al.
Publicado: (2016)

c-Jun N-Terminal Kinase Signaling Inhibitors Under Development
por: Han, Sun-Young
Publicado: (2008)

Regulation of c-Jun NH(2)-Terminal Kinase for Islet Transplantation
por: Noguchi, Hirofumi
Publicado: (2019)

The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases
por: Chen, Jing, et al.
Publicado: (2021)

Critical role of c-jun N-terminal protein kinase in promoting mitochondrial dysfunction and acute liver injury
por: Jang, Sehwan, et al.
Publicado: (2015)

Krox-20 inhibits Jun-NH(2)-terminal kinase/c-Jun to control Schwann cell proliferation and death
por: Parkinson, David B., et al.
Publicado: (2004)

c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury
por: Shvedova, Maria, et al.
Publicado: (2018)

Stressor-Like Effects of c-Jun N-Terminal Kinase (JNK) Inhibition
por: Clarke, Melanie, et al.
Publicado: (2012)

c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity
por: Muñoz-Alonso, María J., et al.
Publicado: (2013)

C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy
por: Klein, SR, et al.
Publicado: (2015)

Activation of c-Jun N-terminal kinase by Akabane virus is required for apoptosis
por: Mitomo, S., et al.
Publicado: (2016)

c-JUN n-Terminal Kinase (JNK) Signaling in Autosomal Dominant Polycystic Kidney Disease
por: Smith, Abigail O., et al.
Publicado: (2022)

Specific inhibition of c-Jun N-terminal kinase delays preterm labour and reduces mortality
por: Pirianov, Grisha, et al.
Publicado: (2015)

Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors
por: Schepetkin, Igor A., et al.
Publicado: (2023)

Activation of the c-Jun NH(2)-terminal kinase pathway by coronavirus infectious bronchitis virus promotes apoptosis independently of c-Jun
por: Fung, To Sing, et al.
Publicado: (2017)

A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer’s Disease: Investigating Structure through Docking Studies
por: Cho, Hyunwook, et al.
Publicado: (2021)

Tolerance to the antinociceptive effects of chronic morphine requires c-Jun N-terminal kinase
por: Marcus, David J., et al.
Publicado: (2015)

Expression of the Alternative Oxidase Influences Jun N-Terminal Kinase Signaling and Cell Migration
por: Andjelković, Ana, et al.
Publicado: (2018)

c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis
por: Bagnoud, Maud, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pkqtf18luvuall38b3ai2gvncr